Adverse clinical outcome in patients with STEMI and a chronic total occlusion (CTO) of a non-infarct related artery — a growing case for CTO revascularization?

By Abdul M. Mozid

There is a growing evidence base suggesting improved clinical outcome in stable patients undergoing successful recanalization of a chronic total occlusion (CTO). The benefits include improvements in symptoms, mortality, and need for future coronary artery bypass surgery. Hypothetically, CTO recanalization in the stable setting maybe also be protective if these patients go on to suffer acute closure of a separate coronary artery due to improved collateral supply to the infarct-related artery.

The prevalence of a CTO in a non-infarct related artery (IRA) in patients presenting with acute STEMI ranges from 7%-21% depending on the demographic of the population studied. Some studies have suggested that multivessel disease (MVD) may only be of prognostic importance if a CTO in a non-IRA is present. In the HORIZONS-AMI trial, the presence of a CTO in the non-IRA was shown to be an independent determinate of early and late mortality. We have performed a retrospective analysis of 1435 patients who have undergone primary PCI at our tertiary center in the United Kingdom. A non-IRA CTO was present in 4.7% of patients presenting with STEMI. We found that the presence of a CTO was an independently predictor of mortality at 30 days, with a three-fold increase in risk, but not for long-term mortality. Our real-world study therefore supports the evidence demonstrating poor prognosis associated with the presence of a CTO in a non-IRA. Furthermore, the data from our study suggest that if CTO revascularization is to be performed, it needs to be carried out earlier rather than later.

A recent observational study of 136 patients with a non-IRA CTO, who underwent successful recanalization of the CTO between 7-10 days after STEMI, demonstrated improved cardiac mortality and event-free survival. The on-going EXPLORE trial, a randomized study of non-IRA CTO revascularization within 1 week of primary PCI, will shed further light on the potential benefit of early intervention.
There is therefore increasing evidence that percutaneous revascularization of CTOs in the stable setting may improve future outcome and there may also now be a case for CTO recanalization in the acute setting following a myocardial infarction.

A thoughtful commentary on the above article also appears in this month’s issue:

Further reading on interventions in non-infarct related arteries:

Advertisements
This entry was posted in Uncategorized and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s